SPECT and PET imaging of the animal shot with hNIS expressing cells. isolated transduced cells by measuring99mTc uptake. NIS+rCDCs were visualized in vivo because regions of99mTc or124I uptake within a perfusion deficit in the SPECT and PET images, respectively. Cells could be visualized by SPECT up to day time 6 Col3a1 post-injection. Ex vivoSPECT confirmed thatin vivo99mTc indicators were localized to the cell injection sites. == Realization == Ectopic NIS manifestation allows no invasivein vivostem cell tracking in the myocardium, using either SPECT or PET. The general approach shows significant guarantee in monitoring the fate of transplanted cells taking part in cardiac regeneration, given its ability to watch living cells using clinically-applicable imaging modalities. Keywords: stem cells, imaging, SPECT, PET == Launch == Stem cells offer the promise of organ restoration on demand. Our pre-clinical studies and studies by other organizations, in small and large animal versions indicate that autologous cardiac-derived stem cells (CDCs) can successfully regenerate myocardium in the setting of ischemic damage (1-4). Despite this initial success, an important problem that continues to be to be tackled is low levels of transplanted cell survival and engraftment (5-7). In vivo stem cell monitoring is a pre-requisite to understanding stem cell biology, optimizing engraftment and maximizing the functional advantages of stem cell therapy in the heart(8). The perfect cell-tracking method should be non-toxic, sensitive, specific for the labeled cells and should allow long-term follow-up(9). Most studies have Isavuconazole used direct labeling of stem cells, with agents such as radionuclides or particles prior to transplantation (8, 9). In this study, we adopted a novel strategy of using a reporter gene (the sodium-iodide symporter) that is normally expressed in the thyroid, belly, choroids plexus and salivary gland (10), but not in the heart, to track CDCs after injection into the heart; the sodium-iodide-symporter (NIS) promotes mobile uptake of iodide or pertechnetate (99mTc) and sodium ions, driven by the transmembrane sodium gradient (11). Amazingly, following ectopic NIS manifestation, only cells over-expressing NIS will uptake99mTc (pertechnetate) or124I after intravenous injection of those tracers, permitting non-invasive, longitudinal monitoring of stem cell engraftment by SPECT and PET respectively. The main advantage of the reporter gene approach over direct stem cell labeling approaches is Isavuconazole that expression in the reporter gene and functional competence in the expressed proteins are determined by cell viability, unlike Isavuconazole direct labeling where the label can be taken up by cardiac myocytes or inflammatory cells after labeled cell death, thus confounding quantification of engraftment(12-14). == Methods == == Cells == Rat CDCs were cultured from Wistar Kyoto rats as previously described(1, 2) (supplemental methods). == Dog model == WKY rats (n=31) underwent myocardial infarction by permanent ligation in the left informe descending coronary artery, following which 1-4 million NIS+syngeneic rCDCs were shot intra-myocardially at 2-4 sites (supplemental methods). == Lentivirus preparation == A third-generation lentiviral vector system was used to labeled the rCDCs(1, 15). Manifestation of the human being NIS gene was driven by constitutively active promoters, CMV (cytomegalovirus promoter) or CAG (composite promoter comprising the CMV enhancer and chicken beta actin promoter-supplemental methods). == Cell proliferation == A colorimetric proliferation assay was performed to test the effect of ectopic NIS expression on CDC viability/function (supplemental methods). In vitroAngiogenesis Assayswere performed as recommended by the producer (Becton-Dickinson, Franklin Lakes, NJ-supplemental methods). In vitro99mTc (pertechnetate) uptakeassay was performed to examine the function of the ectopically expressed NIS (supplemental methods). PCR., Reverse Transcription (RT)-PCR was performed to confirm NIS-expression in myocardium, 24hrs after injection of NIS-labeled rCDCs (supplemental methods). Quantitative PCR for the rat SRY gene was performed on day 1 and day time 8 to confirm CDC engraftment after gender-mismatched rCDC transplantation (supplemental methods). == In vivo imaging == == SPECT/CT == Animals were imaged using a Gamma Medica X-SPECT-CT scanner (Gamma Medica, Northridge, CA, USA). SPECT imaging was performed before PET imaging because124I includes a relatively lengthy half life (4. 2 days) and emits gamma rays that could increase background and decrease contrast during SPECT imaging. The radioisotopes, 99mTc (7. 71. 7 mCi /28563MBq) and210Tl (1mCi/37MBq) were injected via the tail vein Isavuconazole (n=13; 6 received CMV. NIS cells, 5 CAG. NIS and 2 non-transduced rCDCs), 24hrs after CDC injection. In addition , 3 rats injected with 4106CMV. NIS cells were imaged on days 1, 3, 6 and 12 post-transplantation to get longitudinal cell-tracking. Images were acquired 1 hour after tracer injection, since this time point has been associated with peak myocardial accumulation of99mTc in a previous detailed time course study(16). Dual isotope SPECT was performed to shorten check out time. Information regarding the imaging.

SPECT and PET imaging of the animal shot with hNIS expressing cells